Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients taking bisphosphonates for bone metastases may have increased health risks

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.